- Highlights Philips Azurion, the next generation image guided therapy platform to optimize system integration and lab performance - Launches unique portfolio of iFR co-registration technologies, including iFR Roadmap and SyncVision, to enhance stenting strategies and patient care AMSTERDAM, May 16, 2017 /PRNewswire/ -- Royal Philips (NYSE: PHG, AEX: PHIA) will showcase its market-leading image guided therapy solutions at EuroPCR 2017 ( Paris, May 16 – 19, 2017) to advance interventional cardiology and make care more personalized, while optimizing patient care and hospital budgets. This year, the healthcare industry is celebrating the 40 th anniversary of angioplasty, the minimally invasive treatment of obstructed blood vessels, and as a leader in interventional cardiology, Philips is reinforcing its longstanding commitment to transforming cardiac care with meaningful innovations.